Medtronic PLC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NYSE
Medtronic plc has filed definitive additional proxy soliciting materials with the SEC.
NYSE
Medtronic plc announces its 2025 Annual General Meeting agenda, highlighting strong fiscal year 2025 performance, executive compensation, and proposals for corporate governance and capital structure adjustments.
NYSE
Medtronic plc has filed a definitive proxy statement with the SEC regarding its upcoming shareholder meeting.
NYSE
Medtronic's 2024 proxy statement outlines proposals for the annual general meeting, including director elections, auditor ratification, executive compensation approval, and share issuance authorizations.